Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 176

1.

Endometrial safety and bleeding profile of a 17β-estradiol/progesterone oral softgel capsule (TX-001HR).

Mirkin S, Goldstein SR, Archer DF, Pickar JH, Graham S, Bernick B.

Menopause. 2020 Jan 6. doi: 10.1097/GME.0000000000001480. [Epub ahead of print]

PMID:
31913228
2.

O-RADS US Risk Stratification and Management System: A Consensus Guideline from the ACR Ovarian-Adnexal Reporting and Data System Committee.

Andreotti RF, Timmerman D, Strachowski LM, Froyman W, Benacerraf BR, Bennett GL, Bourne T, Brown DL, Coleman BG, Frates MC, Goldstein SR, Hamper UM, Horrow MM, Hernanz-Schulman M, Reinhold C, Rose SL, Whitcomb BP, Wolfman WL, Glanc P.

Radiology. 2020 Jan;294(1):168-185. doi: 10.1148/radiol.2019191150. Epub 2019 Nov 5.

PMID:
31687921
3.

Abnormal Uterine Bleeding.

Khafaga A, Goldstein SR.

Obstet Gynecol Clin North Am. 2019 Dec;46(4):595-605. doi: 10.1016/j.ogc.2019.07.001. Epub 2019 Sep 25. Review.

PMID:
31677744
4.

Simple Adnexal Cysts: SRU Consensus Conference Update on Follow-up and Reporting.

Levine D, Patel MD, Suh-Burgmann EJ, Andreotti RF, Benacerraf BR, Benson CB, Brewster WR, Coleman BG, Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow MM, Hur HC, Marnach ML, Pavlik E, Platt LD, Puscheck E, Smith-Bindman R, Brown DL.

Radiology. 2019 Nov;293(2):359-371. doi: 10.1148/radiol.2019191354. Epub 2019 Sep 24.

PMID:
31549945
5.

Ospemifene for the treatment of menopausal vaginal dryness, a symptom of the genitourinary syndrome of menopause.

Archer DF, Simon JA, Portman DJ, Goldstein SR, Goldstein I.

Expert Rev Endocrinol Metab. 2019 Sep;14(5):301-314. doi: 10.1080/17446651.2019.1657008. Epub 2019 Sep 17.

PMID:
31526199
6.

Efficacy and safety of ospemifene in postmenopausal women with moderate-to-severe vaginal dryness: a phase 3, randomized, double-blind, placebo-controlled, multicenter trial.

Archer DF, Goldstein SR, Simon JA, Waldbaum AS, Sussman SA, Altomare C, Zhu J, Yoshida Y, Schaffer S, Soulban G.

Menopause. 2019 Jan 28;26(6):611-621. doi: 10.1097/GME.0000000000001292.

7.

Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review.

Portman DJ, Goldstein SR, Kagan R.

Climacteric. 2019 Feb;22(1):65-72. doi: 10.1080/13697137.2018.1535583. Epub 2018 Dec 17.

PMID:
30554531
8.

Increased Incidence of Endometrial Cancer Following the Women's Health Initiative: An Assessment of Risk Factors.

Constantine GD, Kessler G, Graham S, Goldstein SR.

J Womens Health (Larchmt). 2019 Feb;28(2):237-243. doi: 10.1089/jwh.2018.6956. Epub 2018 Nov 28.

9.

Appropriate evaluation of postmenopausal bleeding.

Goldstein SR.

Menopause. 2018 Dec;25(12):1476-1478. doi: 10.1097/GME.0000000000001181.

PMID:
30234731
10.

Ovarian-Adnexal Reporting Lexicon for Ultrasound: A White Paper of the ACR Ovarian-Adnexal Reporting and Data System Committee.

Andreotti RF, Timmerman D, Benacerraf BR, Bennett GL, Bourne T, Brown DL, Coleman BG, Frates MC, Froyman W, Goldstein SR, Hamper UM, Horrow MM, Hernanz-Schulman M, Reinhold C, Strachowski LM, Glanc P.

J Am Coll Radiol. 2018 Oct;15(10):1415-1429. doi: 10.1016/j.jacr.2018.07.004. Epub 2018 Aug 24. Erratum in: J Am Coll Radiol. 2019 Mar;16(3):403-406.

PMID:
30149950
11.

Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from Carboxyhemoglobin.

Goldstein SR, Liu C, Safo MK, Nakagawa A, Zapol WM, Winkler JD.

ACS Med Chem Lett. 2018 May 11;9(7):714-718. doi: 10.1021/acsmedchemlett.8b00166. eCollection 2018 Jul 12.

12.

An evidence-based approach to assessing surgical versus clinical diagnosis of symptomatic endometriosis.

Taylor HS, Adamson GD, Diamond MP, Goldstein SR, Horne AW, Missmer SA, Snabes MC, Surrey E, Taylor RN.

Int J Gynaecol Obstet. 2018 Aug;142(2):131-142. doi: 10.1002/ijgo.12521. Epub 2018 May 28. Review.

PMID:
29729099
13.

Ultrasound in menopause: a look back.

Goldstein SR.

Menopause. 2018 Mar;25(3):245-248. doi: 10.1097/GME.0000000000001077. No abstract available.

PMID:
29465502
14.

Rotator Cuff Repair in Adolescent Athletes.

Azzam MG, Dugas JR, Andrews JR, Goldstein SR, Emblom BA, Cain EL Jr.

Am J Sports Med. 2018 Apr;46(5):1084-1090. doi: 10.1177/0363546517752919. Epub 2018 Feb 13.

PMID:
29438628
15.

Abnormal uterine bleeding in perimenopause.

Goldstein SR, Lumsden MA.

Climacteric. 2017 Oct;20(5):414-420. doi: 10.1080/13697137.2017.1358921. Epub 2017 Aug 7. Review.

PMID:
28780893
16.

Transcutaneous Nerve Stimulation for Pain Relief During Office Hysteroscopy: A Randomized Controlled Trial.

Goldstein SR.

Obstet Gynecol. 2017 Jun;129(6):1141. doi: 10.1097/AOG.0000000000002087. No abstract available.

PMID:
28538485
17.

First International Consensus Report on Adnexal Masses: Management Recommendations.

Glanc P, Benacerraf B, Bourne T, Brown D, Coleman BG, Crum C, Dodge J, Levine D, Pavlik E, Timmerman D, Ueland FR, Wolfman W, Goldstein SR.

J Ultrasound Med. 2017 May;36(5):849-863. doi: 10.1002/jum.14197. Epub 2017 Mar 7.

PMID:
28266033
18.

Transvaginal Ultrasound for the Diagnosis of Abnormal Uterine Bleeding.

Wheeler KC, Goldstein SR.

Clin Obstet Gynecol. 2017 Mar;60(1):11-17. doi: 10.1097/GRF.0000000000000257.

PMID:
28005589
19.

Patient considerations in the management of menopausal symptoms: role of conjugated estrogens with bazedoxifene.

Kagan R, Goldstein SR, Pickar JH, Komm BS.

Ther Clin Risk Manag. 2016 Apr 7;12:549-62. doi: 10.2147/TCRM.S63833. eCollection 2016. Review.

20.

The conundrum of asymptomatic adnexal masses: a clinician's opinion.

Goldstein SR.

Am J Obstet Gynecol. 2016 Apr;214(4):422-423. doi: 10.1016/j.ajog.2016.01.161. No abstract available.

PMID:
27017323
21.

Does purified Swedish pollen extract, a nonhormonal treatment for vasomotor symptoms, inhibit the CYP2D6 enzyme system?

Goldstein SR, Espié M, Druckmann R.

Menopause. 2015 Nov;22(11):1212-4. doi: 10.1097/GME.0000000000000535.

PMID:
26325084
22.

Not all SERMs are created equal: chapter 2.

Goldstein SR.

Menopause. 2015 Aug;22(8):802-3. doi: 10.1097/GME.0000000000000504. No abstract available.

PMID:
26102533
23.

Inhibition of JNK Sensitizes Hypoxic Colon Cancer Cells to DNA-Damaging Agents.

Vasilevskaya IA, Selvakumaran M, Hierro LC, Goldstein SR, Winkler JD, O'Dwyer PJ.

Clin Cancer Res. 2015 Sep 15;21(18):4143-52. doi: 10.1158/1078-0432.CCR-15-0352. Epub 2015 May 28.

24.

Consider ultrasound first for imaging the female pelvis.

Benacerraf BR, Abuhamad AZ, Bromley B, Goldstein SR, Groszmann Y, Shipp TD, Timor-Tritsch IE.

Am J Obstet Gynecol. 2015 Apr;212(4):450-5. doi: 10.1016/j.ajog.2015.02.015.

PMID:
25841638
25.

Letter to the editor.

Goldstein SR.

Menopause. 2015 Apr;22(4):475. doi: 10.1097/GME.0000000000000424. No abstract available.

PMID:
25668309
26.

Ovarian conservation at the time of hysterectomy for benign disease: where is the pendulum now?

Goldstein SR.

Climacteric. 2014 Dec;17(6):721-2. doi: 10.3109/13697137.2014.968417. No abstract available.

PMID:
25399702
27.

Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making: a clinical decision-support tool from The North American Menopause Society.

Manson JE, Ames JM, Shapiro M, Gass ML, Shifren JL, Stuenkel CA, Pinkerton JV, Kaunitz AM, Pace DT, Kagan R, Schnatz PF, Kingsberg SA, Liu JH, Joffe H, Richard-Davis G, Goldstein SR, Schiff I, Utian WH.

Menopause. 2015 Mar;22(3):247-53. doi: 10.1097/GME.0000000000000373. No abstract available.

PMID:
25314150
28.

Cystadenofibromas: Can transvaginal ultrasound appearance reduce some surgical interventions?

Goldstein SR, Timor-Tritsch IE, Monteagudo A, Monda S, Popiolek D.

J Clin Ultrasound. 2015 Jul-Aug;43(6):393-6. doi: 10.1002/jcu.22241. Epub 2014 Oct 1.

PMID:
25271400
29.

Why the product labeling for low-dose vaginal estrogen should be changed.

Manson JE, Goldstein SR, Kagan R, Kaunitz AM, Liu JH, Pinkerton JV, Rebar RW, Schnatz PF, Shifren JL, Stuenkel CA, Gass ML, Utian WH; Working Group on Women’s Health and Well-Being in Menopause.

Menopause. 2014 Sep;21(9):911-6. doi: 10.1097/GME.0000000000000316. No abstract available.

PMID:
25140698
30.

Endometrial safety of ospemifene: results of the phase 2/3 clinical development program.

Constantine GD, Goldstein SR, Archer DF.

Menopause. 2015 Jan;22(1):36-43. doi: 10.1097/GME.0000000000000275.

31.

Still another selective estrogen receptor modulator to enhance women's health: this time in combination with conjugated equine estrogens.

Goldstein SR.

Menopause. 2014 Jan;21(1):1-2. doi: 10.1097/GME.0000000000000174. No abstract available.

PMID:
24326285
32.

Application of depression rating scales in patients with Parkinson's disease with and without co-Occurring anxiety.

Calleo J, Williams JR, Amspoker AB, Swearingen L, Hirsch ES, Anderson K, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone GM, Weiss H, Rabins P, Marsh L.

J Parkinsons Dis. 2013;3(4):603-8. doi: 10.3233/JPD-130264.

PMID:
24275604
33.

Diagnostic criteria for nonviable pregnancy early in the first trimester.

Doubilet PM, Benson CB, Bourne T, Blaivas M; Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy, Barnhart KT, Benacerraf BR, Brown DL, Filly RA, Fox JC, Goldstein SR, Kendall JL, Lyons EA, Porter MB, Pretorius DH, Timor-Tritsch IE.

N Engl J Med. 2013 Oct 10;369(15):1443-51. doi: 10.1056/NEJMra1302417. Review. No abstract available.

34.

Osteoporosis risk factors and early life-style modifications to decrease disease burden in women.

Nachtigall MJ, Nazem TG, Nachtigall RH, Goldstein SR.

Clin Obstet Gynecol. 2013 Dec;56(4):650-3. doi: 10.1097/GRF.0b013e3182aa1daf. Review.

PMID:
24100599
35.

Ospemifene 12-month safety and efficacy in postmenopausal women with vulvar and vaginal atrophy.

Goldstein SR, Bachmann GA, Koninckx PR, Lin VH, Portman DJ, Ylikorkala O; Ospemifene Study Group.

Climacteric. 2014 Apr;17(2):173-82. doi: 10.3109/13697137.2013.834493. Epub 2013 Nov 23.

36.

Postmenopausal dyspareunia: has the Food and Drug Administration really helped?

Goldstein SR.

Menopause. 2013 Jun;20(6):596-7. doi: 10.1097/GME.0b013e318291ef83. No abstract available.

PMID:
23676631
37.

Pharmacologic treatment of anxiety disorders in Parkinson disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Palanci J, Rabins PV, Weiss HD, Marsh L.

Am J Geriatr Psychiatry. 2013 Jun;21(6):520-8. doi: 10.1016/j.jagp.2012.10.023. Epub 2013 Mar 29.

38.

Begin with the basics: role of 3-dimensional sonography as a first-line imaging technique in the cost-effective evaluation of gynecologic pelvic disease.

Sakhel K, Benson CB, Platt LD, Goldstein SR, Benacerraf BR.

J Ultrasound Med. 2013 Mar;32(3):381-8. No abstract available.

PMID:
23443177
39.

NICE guidance on ectopic pregnancy and miscarriage restricts access and choice and may be clinically unsafe.

Bourne T, Barnhart K, Benson CB, Brosens J, Van Calster B, Condous G, Coomerasamy A, Doubilet PM, Goldstein SR, Gould D, Kirk E, Mol BW, Raine-Fenning N, Stalder C, Timmerman D.

BMJ. 2013 Jan 22;346:f197. doi: 10.1136/bmj.f197. No abstract available.

PMID:
23341557
40.

Office diagnosis and management of abnormal uterine bleeding.

Tsai MC, Goldstein SR.

Clin Obstet Gynecol. 2012 Sep;55(3):635-50. doi: 10.1097/GRF.0b013e31825d3cec.

PMID:
22828096
41.

A comparison of nine scales to detect depression in Parkinson disease: which scale to use?

Williams JR, Hirsch ES, Anderson K, Bush AL, Goldstein SR, Grill S, Lehmann S, Little JT, Margolis RL, Palanci J, Pontone G, Weiss H, Rabins P, Marsh L.

Neurology. 2012 Mar 27;78(13):998-1006. doi: 10.1212/WNL.0b013e31824d587f. Epub 2012 Mar 14.

42.

Sonography in postmenopausal bleeding.

Goldstein SR.

J Ultrasound Med. 2012 Feb;31(2):333-6. Review. No abstract available.

PMID:
22298878
43.

The sound judgment series.

Goldstein SR.

J Ultrasound Med. 2012 Feb;31(2):189-90. No abstract available.

PMID:
22298860
44.

Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass.

Goldstein SR, Bhattoa HP, Neven P, Cox DA, Dowsett SA, Alam J, Sipos A, Muram D.

Menopause. 2012 Jan;19(1):41-7. doi: 10.1097/gme.0b013e318223bbf4.

PMID:
21993078
45.

Bone health medications: research questions versus clinical choices.

Goldstein SR.

Menopause. 2011 Aug;18(8):835-6. doi: 10.1097/gme.0b013e318223cb6e. No abstract available.

PMID:
21785375
46.

Significance of incidentally thick endometrial echo on transvaginal ultrasound in postmenopausal women.

Goldstein SR.

Menopause. 2011 Apr;18(4):434-6. doi: 10.1097/gme.0b013e31820ad00b. Review.

PMID:
21701429
47.

Introduction to a special section on the causality, diagnosis, and management of abnormal uterine bleeding.

Goldstein SR.

Menopause. 2011 Apr;18(4):406-7. doi: 10.1097/gme.0b013e31821433c6. No abstract available.

PMID:
21701424
48.

Anxiety and self-perceived health status in Parkinson's disease.

Pontone GM, Williams JR, Anderson KE, Chase G, Goldstein SR, Grill S, Hirsch ES, Lehmann S, Little JT, Margolis RL, Rabins PV, Weiss HD, Marsh L.

Parkinsonism Relat Disord. 2011 May;17(4):249-54. doi: 10.1016/j.parkreldis.2011.01.005. Epub 2011 Feb 2.

49.

Reflections on Beryl Benacerraf.

Goldstein SR.

J Ultrasound Med. 2010 Dec;29(12):1683. No abstract available.

PMID:
21098837
50.

Management of asymptomatic ovarian and other adnexal cysts imaged at US Society of Radiologists in Ultrasound consensus conference statement.

Levine D, Brown DL, Andreotti RF, Benacerraf B, Benson CB, Brewster WR, Coleman B, DePriest P, Doubilet PM, Goldstein SR, Hamper UM, Hecht JL, Horrow M, Hur HC, Marnach M, Patel MD, Platt LD, Puscheck E, Smith-Bindman R; Society of Radiologists in Ultrasound.

Ultrasound Q. 2010 Sep;26(3):121-31. doi: 10.1097/RUQ.0b013e3181f09099. Review.

PMID:
20823748

Supplemental Content

Loading ...
Support Center